Validation of Cancer Cases Using Primary Care, Cancer Registry, and Hospitalization Data in the United Kingdom

par Margulis, Andrea V., Fortuny, Joan, Kaye, James A., Calingaert, Brian, Reynolds, Maria, Plana, Estel, McQuay, Lisa J., Atsma, Willem Jan, Franks, Billy, de Vogel, Stefan, Perez-Gutthann, Susana, Arana, Alejandro
Publié dans Epidemiology (2018)

Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom

par Arana, Alejandro, Margulis, Andrea V, Varas‐Lorenzo, Cristina, Bui, Christine L, Gilsenan, Alicia, McQuay, Lisa J, Reynolds, Maria, Rebordosa, Cristina, Franks, Billy, de Vogel, Stefan, Appenteng, Kwame, Perez‐Gutthann, Susana
Publié dans Pharmacoepidemiol Drug Saf (2020)

Physical activity and risk of prostate and bladder cancer in China: The South and East China case-control study on prostate and bladder cancer

par Reulen, Raoul C., de Vogel, Stefan, Zhong, Weide, Zhong, Zhaohui, Xie, Li-Ping, Hu, Zhiquan, Deng, Yilan, Yang, Kai, Liang, Yuxiang, Zeng, Xing, Wong, Yong Chuan, Tam, Po-Chor, Hemelt, Marjolein, Zeegers, Maurice P.
Publié dans PLoS One (2017)

Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four Europ...

par Heintjes, Edith M, Bezemer, Irene D, Prieto-Alhambra, Daniel, Smits, Elisabeth, Booth, Helen P, Dedman, Daniel, He, Ying, Hoti, Fabian, Vehkala, Minna, de Vogel, Stefan, Robinson, Noah Jamie, Appenteng, Kwame, Penning-van Beest, Fernie J A
Publié dans Clin Epidemiol (2020)

Dietary methyl donors, methyl metabolizing enzymes, and epigenetic regulators: diet–gene interactions and promoter CpG island hypermethylation in colorectal cancer

par de Vogel, Stefan, Wouters, Kim A. D., Gottschalk, Ralph W. H., van Schooten, Frederik J., de Goeij, Anton F. P. M., de Bruïne, Adriaan P., Goldbohm, R. Alexandra, van den Brandt, Piet A., van Engeland, Manon, Weijenberg, Matty P.
Publié 2010

Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study

par Hoffman, Veena, Hallas, Jesper, Linder, Marie, Margulis, Andrea V., Suehs, Brandon T., Arana, Alejandro, Phiri, Kelesitse, Enger, Cheryl, Horter, Libby, Odsbu, Ingvild, Olesen, Morten, Perez-Gutthann, Susana, Xu, Yihua, Kristiansen, Nina Sahlertz, Appenteng, Kwame, de Vogel, Stefan, Seeger, John D.
Publié dans Drug Saf (2021)

Circulating Folate and Vitamin B(12) and Risk of Prostate Cancer: A Collaborative Analysis of Individual Participant Data from Six Cohorts Including 6875 Cases and 8104 Controls

par Price, Alison J., Travis, Ruth C., Appleby, Paul N., Albanes, Demetrius, Barricarte Gurrea, Aurelio, Bjørge, Tone, Bueno-de-Mesquita, H. Bas, Chen, Chu, Donovan, Jenny, Gislefoss, Randi, Goodman, Gary, Gunter, Marc, Hamdy, Freddie C., Johansson, Mattias, King, Irena B., Kühn, Tilman, Männistö, Satu, Martin, Richard M., Meyer, Klaus, Neal, David E., Neuhouser, Marian L., Nygård, Ottar, Stattin, Par, Tell, Grethe S., Trichopoulou, Antonia, Tumino, Rosario, Ueland, Per Magne, Ulvik, Arve, de Vogel, Stefan, Vollset, Stein Emil, Weinstein, Stephanie J., Key, Timothy J., Allen, Naomi E.
Publié dans Eur Urol (2016)